These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

232 related articles for article (PubMed ID: 19229816)

  • 1. Metabolic syndrome: at the crossroads of cardiorenal risk.
    Natali A; Pucci G; Boldrini B; Schillaci G
    J Nephrol; 2009; 22(1):29-38. PubMed ID: 19229816
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Metabolic syndrome.
    Vitale C; Marazzi G; Volterrani M; Aloisio A; Rosano G; Fini M
    Minerva Med; 2006 Jun; 97(3):219-29. PubMed ID: 16855517
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The metabolic syndrome and chronic kidney disease.
    Peralta CA; Kurella M; Lo JC; Chertow GM
    Curr Opin Nephrol Hypertens; 2006 Jul; 15(4):361-5. PubMed ID: 16775449
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cardiovascular risk factors in the metabolic syndrome: impact of insulin resistance on lipids, hypertension, and the development of diabetes and cardiac events.
    Zarich SW
    Rev Cardiovasc Med; 2005; 6(4):194-205. PubMed ID: 16379015
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Metabolic syndrome in Portugal: prevalence and implications for cardiovascular risk--results from the VALSIM Study.
    Fiuza M; Cortez-Dias N; Martins S; Belo A;
    Rev Port Cardiol; 2008 Dec; 27(12):1495-529. PubMed ID: 19280993
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Obesity, insulin resistance and kidney disease risk: insights into the relationship.
    Sarafidis PA
    Curr Opin Nephrol Hypertens; 2008 Sep; 17(5):450-6. PubMed ID: 18695384
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The emerging link between hypogonadism and metabolic syndrome.
    Guay AT
    J Androl; 2009; 30(4):370-6. PubMed ID: 18772486
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Metabolic syndrome in severe chronic kidney disease: Prevalence, predictors, prognostic significance and effects of risk factor modification.
    Johnson DW; Armstrong K; Campbell SB; Mudge DW; Hawley CM; Coombes JS; Prins JB; Isbel NM
    Nephrology (Carlton); 2007 Aug; 12(4):391-8. PubMed ID: 17635756
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Metabolic syndrome and cardiovascular risk in primary hypertension.
    Ratto E; Leoncini G; Viazzi F; Vaccaro V; Parodi A; Falqui V; Conti N; Tomolillo C; Deferrari G; Pontremoli R
    J Am Soc Nephrol; 2006 Apr; 17(4 Suppl 2):S120-2. PubMed ID: 16565234
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The metabolic syndrome as a risk factor for venous and arterial thrombosis.
    Dentali F; Squizzato A; Ageno W
    Semin Thromb Hemost; 2009 Jul; 35(5):451-7. PubMed ID: 19739035
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sleep and the metabolic syndrome.
    Wolk R; Somers VK
    Exp Physiol; 2007 Jan; 92(1):67-78. PubMed ID: 17085678
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Glucose, insulin, diabetes and mechanisms of arterial dysfunction.
    Cameron JD; Cruickshank JK
    Clin Exp Pharmacol Physiol; 2007 Jul; 34(7):677-82. PubMed ID: 17581229
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comorbidities in polycystic ovary syndrome: their relationship to insulin resistance.
    Bethea SW; Nestler JE
    Panminerva Med; 2008 Dec; 50(4):295-304. PubMed ID: 19078870
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Epidemiology of non-dialysis-requiring chronic kidney disease and cardiovascular disease.
    Go AS; Lo JC
    Curr Opin Nephrol Hypertens; 2006 May; 15(3):296-302. PubMed ID: 16609298
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Metabolic syndrome and the menopause.
    Kaaja RJ
    Menopause Int; 2008 Mar; 14(1):21-5. PubMed ID: 18380957
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Current understanding of multiple risk factors as the metabolic syndrome: distillation or deconstruction.
    Boden-Albala B
    Semin Neurol; 2006 Feb; 26(1):108-16. PubMed ID: 16479449
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Cardiovascular risk stratification. Systolic, diastolic or pulse pressure?].
    Pede S; Lombardo M
    Ital Heart J Suppl; 2001 Apr; 2(4):356-8. PubMed ID: 19397006
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison between Turkish Cardiovascular Risk Platform and United States National Cholesterol Education Program Adult Treatment Panel III definitions of the metabolic syndrome in Turkish adults.
    Can AS; Ozbayrakçi S; Palaoğlu KE; Bersot TP
    J Cardiometab Syndr; 2009; 4(1):26-32. PubMed ID: 19245513
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Does the metabolic syndrome add to the diagnosis and treatment of cardiovascular disease?
    de Zeeuw D; Bakker SJ
    Nat Clin Pract Cardiovasc Med; 2008 Jul; 5 Suppl 1():S10-4. PubMed ID: 18580860
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Metabolic syndrome: a child is not a small adult.
    Pietrobelli A; Malavolti M; Battistini NC; Fuiano N
    Int J Pediatr Obes; 2008; 3 Suppl 1():67-71. PubMed ID: 18278635
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.